GI and Liver COVID Task Force Statement on the Hepatic Safety of Molnupiravir as an Oral Antiviral Treatment for COVID-19webManager012024-09-13T14:00:55+08:00
PSG, PSDE, HSP Joint annual convention (JAC) 2022: Redefining the future of GI healthcare in the Philippines and the worldwebManager012024-10-20T00:01:13+08:00